China National Accord Medicines Corp. Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000009N6
CNY
24.53
0.01 (0.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
17,823.41
18,291.37
18,327.89
18,503.08
18,293.52
17,912.14
18,680.37
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
17,823.41
18,291.37
18,327.89
18,503.08
18,293.52
17,912.14
18,680.37
Raw Material Cost
16,048.36
16,526.05
16,774.95
16,824.20
16,761.61
16,225.06
17,105.37
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
33.33
63.18
40.22
47.47
43.63
59.75
67.47
Selling and Distribution Expenses
1,388.64
1,245.74
1,109.64
1,176.61
1,095.31
1,351.32
1,160.37
Other Expenses
-3.18
-6.02
-3.58
-4.22
-3.82
-5.49
-6.17
Total Expenditure (Excl Depreciation)
17,438.51
17,774.75
17,889.05
18,006.04
17,862.37
17,581.22
18,271.55
Operating Profit (PBDIT) excl Other Income
384.90000000000003
516.5999999999999
438.8
497
431.1
330.90000000000003
408.8
Other Income
2.96
-15.92
-5.66
2.03
-2.91
-56.15
20.92
Operating Profit (PBDIT)
340.06
716.26
683.53
866.97
801.21
-317.86
821.62
Interest
33.33
63.18
40.22
47.47
43.63
59.75
67.47
Exceptional Items
0.00
-254.02
3.23
0.00
0.00
-23.82
0.00
Gross Profit (PBDT)
1,775.05
1,765.32
1,552.94
1,678.88
1,531.91
1,687.08
1,575.01
Depreciation
0.00
295.21
295.21
419.47
419.47
438.83
438.83
Profit Before Tax
306.73
103.86
351.34
400.03
338.11
-840.26
315.32
Tax
71.70
82.41
92.74
114.87
90.65
77.67
72.88
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
287.46
178.81
291.21
337.91
328.00
-423.05
322.05
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
287.46
178.81
291.21
337.91
328.00
-423.05
322.05
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
17.70
-69.86
15.59
27.01
19.68
-435.62
3.56
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
305.16
108.95
306.80
364.92
347.68
-858.67
325.61
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
18,897.43
18,609.96
18,429.95
18,136.17
17,997.53
17,669.53
18,101.88
Earnings per share (EPS)
0.52
0.32
0.52
0.61
0.59
-0.76
0.58
Diluted Earnings per share
0.52
0.32
0.52
0.61
0.59
-0.76
0.58
Operating Profit Margin (Excl OI)
1.89%
2.39%
2.15%
2.41%
2.1%
-3.91%
1.94%
Gross Profit Margin
1.72%
2.18%
3.53%
4.43%
4.14%
-2.24%
4.04%
PAT Margin
1.61%
0.98%
1.59%
1.83%
1.79%
-2.36%
1.72%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -2.56% vs -0.20% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 180.00% vs -64.47% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -53.96% vs 6.24% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -47.31% vs 57.21% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of China National Accord Medicines Corp. Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
17,823.41
0
17,823.41
Other Operating Income
0.00
0.00
0.00
Total Operating income
17,823.41
0
17,823.41
Raw Material Cost
16,048.36
0
16,048.36
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
33.33
0
33.33
Selling and Distribution Expenses
1,388.64
0
1,388.64
Other Expenses
-3.18
0.00
-3.18
Total Expenditure (Excl Depreciation)
17,438.51
0
17,438.51
Operating Profit (PBDIT) excl Other Income
384.90
0.00
384.90
Other Income
2.96
0
2.96
Operating Profit (PBDIT)
340.06
0
340.06
Interest
33.33
0
33.33
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
1,775.05
0
1,775.05
Depreciation
0.00
0
0.00
Profit Before Tax
306.73
0
306.73
Tax
71.70
0
71.70
Provisions and contingencies
0
0
0.00
Profit After Tax
287.46
0
287.46
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
287.46
0
287.46
Share in Profit of Associates
0
0
0.00
Minority Interest
17.70
0
17.70
Other related items
0.00
0.00
0.00
Consolidated Net Profit
305.16
0
305.16
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
18,897.43
0
18,897.43
Earnings per share (EPS)
0.52
0
0.52
Diluted Earnings per share
0.52
0
0.52
Operating Profit Margin (Excl OI)
1.89%
0%
0.00
1.89%
Gross Profit Margin
1.72%
0%
0.00
1.72%
PAT Margin
1.61%
0%
0.00
1.61%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,782.34 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -2.56% vs -0.20% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -2.57% vs -4.17% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 30.52 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 180.00% vs -64.47% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -12.22% vs -22.06% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 33.71 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -53.96% vs 6.24% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -58.08% vs -10.46% in Mar 2025

Quarterly - Interest
Interest 3.33 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -47.31% vs 57.21% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -23.62% vs -20.29% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.89%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025